Crystal Pharmatech Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 180

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Latest Deal Amount
  • $92.8M

  • Investors
  • 7

Crystal Pharmatech General Information

Description

Developer and provider of solid-state chemistry services intended to focus on material science and engineering for drug development. The company's services include a range of services from screening and evaluation to processing for active pharmaceutical ingredients and formulations, serving the pharmaceutical industry to develop new drugs efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 288, Jiangyun Road
  • Suzhou Industrial Park
  • Suzhou, Jiangsu 215123
  • China
+86 0512
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • Number 288, Jiangyun Road
  • Suzhou Industrial Park
  • Suzhou, Jiangsu 215123
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Crystal Pharmatech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 02-Oct-2021 $92.8M Cancelled Profitable
6. Accelerator/Incubator 01-Jan-2022 Completed Profitable
5. Secondary Transaction - Private 09-Mar-2020 Completed Profitable
4. Secondary Transaction - Private 31-Oct-2019 Completed Profitable
3. Later Stage VC (Series B) 07-Nov-2018 Completed Profitable
2. Later Stage VC 18-Sep-2017 $5.38M $15.4M Completed Profitable
1. Later Stage VC (Series A) 16-Sep-2015 $10M $10M Completed Generating Revenue
To view Crystal Pharmatech’s complete valuation and funding history, request access »

Crystal Pharmatech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Crystal Pharmatech’s complete cap table history, request access »

Crystal Pharmatech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and provider of solid-state chemistry services intended to focus on material science and engineering for drug
Other Pharmaceuticals and Biotechnology
Suzhou, China
180 As of 2019

Wilmington, MA
 

Kolkata, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Crystal Pharmatech Competitors (34)

One of Crystal Pharmatech’s 34 competitors is Charles River Laboratories International, a Formerly PE-Backed company based in Wilmington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Charles River Laboratories International Formerly PE-Backed Wilmington, MA
TCG Lifesciences Corporation Kolkata, India
Caidya Private Equity-Backed Raleigh, NC
Accell Clinical Research Corporation Warrenton, VA
KBI BioPharma Formerly VC-backed Durham, NC
You’re viewing 5 of 34 competitors. Get the full list »

Crystal Pharmatech Patents

Crystal Pharmatech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026208703-A1 Crystal form of vidofludimus calcium, preparation method therefor, and use thereof Pending 03-Apr-2025
WO-2025167588-A1 Crystal form of zipalertinib, and preparation method therefor and use thereof Pending 05-Feb-2024
WO-2025140479-A1 Crystal form of iclepertin, preparation method therefor, and use thereof Inactive 29-Dec-2023
WO-2025107861-A1 Crystal form of zasocitinib, preparation method therefor and use thereof Inactive 24-Nov-2023
WO-2025026050-A1 Crystal form of bezuclastinib, preparation method therefor and use thereof Inactive 28-Jul-2023 C07D471/04
To view Crystal Pharmatech’s complete patent history, request access »

Crystal Pharmatech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Crystal Pharmatech Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
CONNECT (San Diego) Accelerator/Incubator
Suzhou Junshang Investment Management Growth/Expansion Minority
Tsinghua Holdings Capital Growth/Expansion Minority
Cowin Capital Venture Capital Minority
Shiyu Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Crystal Pharmatech Investments (4)

Crystal Pharmatech’s most recent deal was a Seed Round with Giiant Pharma for . The deal was made on 30-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Giiant Pharma 30-Jun-2021 Seed Round Drug Discovery
Chiral Quest 01-Feb-2021 Corporate Other Pharmaceuticals and Biotechnology
Laviana 18-Apr-2018 Later Stage VC Clinics/Outpatient Services
F&S Pharmatech 21-Oct-2015 Corporate Other Pharmaceuticals and Biotechnology
To view Crystal Pharmatech’s complete investments history, request access »

Crystal Pharmatech FAQs

  • When was Crystal Pharmatech founded?

    Crystal Pharmatech was founded in 2010.

  • Where is Crystal Pharmatech headquartered?

    Crystal Pharmatech is headquartered in Suzhou, China.

  • What is the size of Crystal Pharmatech?

    Crystal Pharmatech has 180 total employees.

  • What industry is Crystal Pharmatech in?

    Crystal Pharmatech’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Crystal Pharmatech a private or public company?

    Crystal Pharmatech is a Private company.

  • What is the current valuation of Crystal Pharmatech?

    The current valuation of Crystal Pharmatech is .

  • What is Crystal Pharmatech’s current revenue?

    The current revenue for Crystal Pharmatech is .

  • How much funding has Crystal Pharmatech raised over time?

    Crystal Pharmatech has raised $37M.

  • Who are Crystal Pharmatech’s investors?

    CONNECT (San Diego), Suzhou Junshang Investment Management, Tsinghua Holdings Capital, Cowin Capital, and Shiyu Capital are 5 of 7 investors who have invested in Crystal Pharmatech.

  • Who are Crystal Pharmatech’s competitors?

    Charles River Laboratories International, TCG Lifesciences, Caidya, Accell Clinical Research, and KBI BioPharma are some of the 34 competitors of Crystal Pharmatech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process